Medgenics Appoints Wilbur H. Gantz to its Board of Directors

Medgenics, Inc. announced the appointment of Wilbur H. (Bill) Gantz to the company's Board of Directors effective October 16, 2013. With this appointment, the size of the Medgenics board increases to 10 directors. Mr. Gantz is President of PathoCapital.

He previously served as Executive Chairman and Chief Executive Officer of Ovation Pharmaceuticals, Inc., and as Chairman, Chief Executive Officer and President of PathoGenesis Corporation. Mr. Gantz is currently Executive Chairman, Naurex, Inc.